Dr Philip Larkman Flashcards
What is the name of the drug which treats general anxiety?
Serotonin selective reuptake inhibitors antidepressants
Name of the axis which have a role in anxiety and depression
HPA axis (hypothalamic - pituitary - adrenal)
Which part of the brain regulates the release of corticotropin releasing factor (CRF)?
Amyglada and hippocampus
which part of the brain exerts an excitatory influence on CRF release? and which exerts an inhibitory effect?
hippocampus: inhibitory
amyglada: excitatory
what changes in the HPA pathway may udnerlie the cause of GA?
chronic activation of the HPA pathway
name three main drugs used to treat generalised anxiety
benzodiazepiene, 5-HT1A partial agonists, SSRIs (serotonin selective reuptake inhibitors)- antidepressants
what is thought to underlie chronic anxiety?
overactivation of the amyglada
where does the main activity of benzodiazepines lies? what is the effect of substituting the four main substituent groups?
activity lies in the aromatic ring and substituting the subtituent group would not alter the activity but do affect the pharmacokinetics
what type of modulator is BDZ? and how does BDZ have an effect on GABA-A receptor?
BDZ is a positive allosteric modulators which enhances GABA action by increasing Cl- conductance
which receptor does BDZ binds to?
GABA-A
what is need to be present in order for BDZ binding to work and why is this the case?
agonist needs to be present. BDZ works by altering the action of agonist by binding to an accessory site.
Does BDZ modulates the affinity or efficacy?
modulates affinity - because it enhances GABA affinity to its receptor (in fact BDZ and GABA enhance each other’s affinity)
whereas efficacy modulators affect channel activity (activation/gating)
How does BDZs increase Cl- conductance?
increase the number of open channels without altering individual channel conductance or opening time.
REMEMBER: the amount of Cl- going through the channel is still the same but conductance is higher because more channel opens
which subunit has sensitivity to BDZ?
the adjacent alpha and gamma subunit
which GABA-A receptors alpha subunit does not confer sensitivity to BDZ?
alpha-4 and alpha-6
what class of drug is flumazenil? Does it have an effect on GABA activity?
competitive antagonist for BDZ binding site, therefore it blocks BDZ. Neutral allosteric modulator, does not alter GABA activity
what does the ligand beta-carbolise-3-carboxylate do?
it is an inverse agonists. It has opposite effect of BDZ although binds to the BDZ binding site (induced anxiety)
explain how BDZ enhances GABA affinity and how inverse agonist counteract this effect
GABA only binds to one configuration of the receptor. BDZs stabilises this configuration. Whereas inverse agonist binds to the non-GABA-binding configuration
which drug can be used for alcohol-withdrawal syndrome?
BDZs, because alcohol also has a binding site in the GABA-A receptor
list down the 4 main clinical uses of BDZs
- reduce anxiety
- hypnotic/sedative effect (pre-operative sedation)
- anti-convulsant effects (reduces hyper excitability, for epilepsy)
- muscle relaxants
- use for alcohol-withdrawal syndrome
what amino acid substitution is found to underlie the insensitivity of alpha-4 and 6 subunit to BDZs?
substitute histidine for arginine at position 101 (H101R)
diazepam is benzodiazepeine
ok.
what was observed in the knock-in mutation when alpha-1 subunit is made insensitive to BDZ?
No sedative effect and anticonvulsant effect but the anxiolytic and muscle relaxant effect is still present. This demonstrate that the alpha-1 subunit mediates the sedative and anticonvulsant effect
How does barbiturates treat anxiety?
enhance Cl- influx by PROLONGING channel opening time. Therefor it modulates the efficacy
How does barbiturates treat anxiety?
enhance Cl- influx by PROLONGING channel opening time when activated by GABA. Therefor it modulates the efficacy
how does the substituent groups in BDZ affect its pharmacokinetics?
It can prolong the metabolic route resulting in long action duration
diazepam, alprazolam, oxazepam and chlordiazepoxide arrange them starting with the shortest half-life, which one do not have active metabolite?
oxazepam, alprazolam, diazepam and chlordiazepoxide.
oxazepam do not have any active metabolite
name three properties of BDZs
- bind strongly to plasma protein
- high lipid solubility therefore cross the blood-brain barrier rapidly
- well absorb from the gut
what are the two factors that taken into consideration when treating elderly with BDZs which affect the pharmacokinetics? how do these factors influence the half-life of BDZs?
- activity of hepatic microsomal enzymes
- a greater proportion of body mass is fat in the elderly
these factors increase the half-life of BDZs because:
- metabolism is decreased
- more is sequestered by fat reserves because of its lipid solubility
which drug is use to reverse the effect of BDZs in case of acute overdose?
flumenazil
list down the unwanted side effects of BDZs
- acute overdose: not lethal unless associated with alcohol
2. therapeutic use: sedative, hypnotic, amnesia,
list down the unwanted side effects of BDZs
- acute overdose: not lethal unless associated with alcohol
- therapeutic use: drowsiness, amnesia, confusion and impaired motor function
- tolerance: tissue tolerance does occur due to receptor changes
- dependence: withdrawal symptoms include elevated anxiety, insomnia. short acting BDZs like Oxazepam shows more abrupt withdrawal symptoms
name an example of 5-HT1A agonists, what does it treat? what type of agonist is this drug?
buspirone for treating anxiety, it is a partial agonist
which type of 5-HT receptor was implicated to be associated wit anxiety and depression?
5-HT1A
Where does the 5-HT1A located and what does it do?
5-HT1A is located pre- (as auto receptor) and post-synaptically in neurons releasing 5-HT. pre synaptically, it limits 5-HT release (inhibitory). post-synaptically it has an inhibitory actions on excitability predominantly.
explain briefly the mechanism of 5-HT1A receptor
5-HT1A receptor inhibits adenylate cyclase, activation of K+ channels and inhibition of Ca2+ channels
how does the expression and function of 5-HT1A receptor change in anxiety? and how does busporine and SSRI act on this change?
abnormal expression and function lead to reduce post-synaptic 5-HT release
busporine and SSRI normalise this by promoting desensitisation of auto receptors without affecting post-synaptic receptors
list the unwanted side effects of busporine
nausea, dizziness, headache and restlessness
what are the two explanations which explains why the effect of busporine on 5-HT1A takes several weeks to achieve maximal therapeutic effect?
- slow effects on autoreceptor function
- neurogenesis
this also demonstrate that busporine and SSRI act through indirect mechanism